AngioDynamics gains expanded coverage for VenaCure:
This article was originally published in Clinica
Executive Summary
AngioDynamics is to see its VenaCure endovenous laser ablation system - formerly known as ELVS - added to US healthcare insurance company Anthem's list of Medicare-covered treatments for varicose veins. With this expanded coverage, "the total number of eligible covered lives for the VenaCure procedure now exceeds 150 million [patients] in the US", says Queensbury, New York-based AngioDynamics. The VenaCure system, cleared by the FDA in 2002, is marketed as a quick, no-fuss, minimally invasive alternative to the traditional ligation and stripping method of treating varicose veins. It is performed on an outpatient basis and under local anaesthetic.